Novartis has made significant strides in cancer treatment through its extensive research and development efforts. The company is known for its targeted therapies, such as kinase inhibitors and monoclonal antibodies. These treatments are designed to specifically attack cancer cells while sparing healthy tissue, thereby reducing side effects and improving patient outcomes.
